Patents by Inventor Diana F. Hausman

Diana F. Hausman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF USING A BISPECIFIC ANTIGEN-BINDING CONSTRUCT TARGETING HER2 FOR THE TREATMENT OF BILIARY TRACT CANCERS
    Publication number: 20220133903
    Abstract: Described herein is a method of treating biliary tract cancer (BTC) comprising administering a bispecific antigen-binding construct targeting HER2 or a bispecific antigen-binding construct targeting HER2 linked to an auristatin analogue (ADC) to a subject.
    Type: Application
    Filed: November 19, 2021
    Publication date: May 5, 2022
    Inventors: Diana F. Hausman, Neil C. Josephson, Rose Kamyee Lai, Gerald James Rowse, Patrick Kaminker
  • METHODS OF USING A BISPECIFIC ANTIGEN-BINDING CONSTRUCT TARGETING HER2 IN COMBINATION WITH CDK4/6 INHIBITORS FOR THE TREATMENT OF BREAST CANCER
    Publication number: 20210170023
    Abstract: Described herein is a method of treating breast cancer comprising administering a bispecific antigen-binding construct targeting HER2 or a bispecific antigen-binding construct targeting HER2 linked to an auristatin analogue (ADC) in combination with a CDK4/6 inhibitor to a subject.
    Type: Application
    Filed: May 29, 2020
    Publication date: June 10, 2021
    Inventors: Nina E. Weisser, Diana F. Hausman, Patrick Kaminker
  • MUC1 Based Glycolipopeptide Vaccine with Adjuvant
    Publication number: 20150064240
    Abstract: Provided herein are liposomal glycolipopeptidic vaccine formulations comprising an adjuvant and an immunogen for immunotherapy and/or treatment of cancer.
    Type: Application
    Filed: September 17, 2014
    Publication date: March 5, 2015
    Inventors: Scott PETERSON, Linda PESTANO, Jeffrey MILLARD, Diana F. HAUSMAN, Sandy KOPPENOL, Robert KIRKMAN
  • MUC1 based glycolipopeptide vaccine with adjuvant
    Patent number: 8889616
    Abstract: Provided herein are liposomal glycolipopeptidic vaccine formulations comprising an adjuvant and an immunogen for immunotherapy and/or treatment of cancer.
    Type: Grant
    Filed: February 23, 2012
    Date of Patent: November 18, 2014
    Assignee: Oncothyreon Inc.
    Inventors: Scott Peterson, Linda Pestano, Jeffrey Millard, Diana F. Hausman, Sandy Koppenol, Robert Kirkman
  • Combination Cancer Therapies with Wortmannin Analogs
    Publication number: 20130129720
    Abstract: Provided herein are combination therapies for the treatment of certain cancers in a subject by administering a combination of a therapeutic and a wortmannin analog to that subject.
    Type: Application
    Filed: June 3, 2011
    Publication date: May 23, 2013
    Applicant: ONCOTHYREON INC.
    Inventors: Scott Peterson, Diana F. Hausman, Robert Kirkman
  • Cancer Treatment with Wortmannin Analogs
    Publication number: 20130131156
    Abstract: Provided herein are certain therapeutically effective dosing regimens for treatment of cancers with wortmannin analogs.
    Type: Application
    Filed: June 3, 2011
    Publication date: May 23, 2013
    Applicant: ONCOTHYREON INC.
    Inventors: Scott Peterson, Diana F. Hausman, Robert Kirkman
  • MUC1 based glycolipopeptide vaccine with adjuvant
    Patent number: 8329639
    Abstract: Provided herein are liposomal glycolipopeptidic vaccine formulations comprising an adjuvant and an immunogen for immunotherapy and/or treatment of cancer.
    Type: Grant
    Filed: July 19, 2012
    Date of Patent: December 11, 2012
    Assignee: Oncothyreon Inc.
    Inventors: Scott Peterson, Linda Pestano, Jeffrey Millard, Diana F. Hausman, Sandy Koppenol, Robert Kirkman
  • MUC1 Based Glycolipopeptide Vaccine with Adjuvant
    Publication number: 20120282329
    Abstract: Provided herein are liposomal glycolipopeptidic vaccine formulations comprising an adjuvant and an immunogen for immunotherapy and/or treatment of cancer.
    Type: Application
    Filed: July 19, 2012
    Publication date: November 8, 2012
    Applicant: Oncothyreon Inc.
    Inventors: Scott PETERSON, Linda Pestano, Jeffrey Millard, Diana F. Hausman, Sandy Koppenol, Robert Kirkman
  • MUC1 Based Glycolipopeptide Vaccine with Adjuvant
    Publication number: 20120219617
    Abstract: Provided herein are liposomal glycolipopeptidic vaccine formulations comprising an adjuvant and an immunogen for immunotherapy and/or treatment of cancer.
    Type: Application
    Filed: February 23, 2012
    Publication date: August 30, 2012
    Applicant: Oncothyreon Inc.
    Inventors: Scott PETERSON, Linda Pestano, Jeffrey Millard, Diana F. Hausman, Sandy Koppenol, Robert Kirkman
  • USE OF PEGYLATED TYPE III INTERFERONS FOR THE TREATMENT OF HEPATITIS C
    Publication number: 20110165121
    Abstract: Methods for treating human patients infected with the hepatitis C virus using pegylated Type III Interferons (IL-28A, IL-28B and IL-29) alone or in combination with other antiviral agents.
    Type: Application
    Filed: June 5, 2009
    Publication date: July 7, 2011
    Inventors: Diana F. Hausman, Michael G. Dodds